Acarbose - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for acarbose and what is the scope of patent protection?
Acarbose
is the generic ingredient in two branded drugs marketed by Avet Lifesciences, Dash Pharms, Hangzhou Zhongmei, Hikma, Impax Labs, Somerset Theraps Llc, Strides Pharma, Watson Labs, and Bayer Hlthcare, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.There are six drug master file entries for acarbose. Ten suppliers are listed for this compound.
Summary for acarbose
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 9 |
| NDAs: | 9 |
| Drug Master File Entries: | 6 |
| Finished Product Suppliers / Packagers: | 10 |
| Raw Ingredient (Bulk) Api Vendors: | 80 |
| Clinical Trials: | 93 |
| Patent Applications: | 6,850 |
| Drug Prices: | Drug price trends for acarbose |
| What excipients (inactive ingredients) are in acarbose? | acarbose excipients list |
| DailyMed Link: | acarbose at DailyMed |
Recent Clinical Trials for acarbose
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Empros Pharma AB | Phase 1 |
| CTC Clinical Trial Consultants AB | Phase 1 |
| University of Zambia | Phase 3 |
Pharmacology for acarbose
| Drug Class | alpha-Glucosidase Inhibitor |
| Mechanism of Action | alpha Glucosidase Inhibitors |
Medical Subject Heading (MeSH) Categories for acarbose
Anatomical Therapeutic Chemical (ATC) Classes for acarbose
US Patents and Regulatory Information for acarbose
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | ACARBOSE | acarbose | TABLET;ORAL | 078470-001 | May 7, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hangzhou Zhongmei | ACARBOSE | acarbose | TABLET;ORAL | 213821-003 | Aug 18, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dash Pharms | ACARBOSE | acarbose | TABLET;ORAL | 091053-003 | Jan 6, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hangzhou Zhongmei | ACARBOSE | acarbose | TABLET;ORAL | 213821-002 | Aug 18, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Avet Lifesciences | ACARBOSE | acarbose | TABLET;ORAL | 202271-002 | Feb 7, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Strides Pharma | ACARBOSE | acarbose | TABLET;ORAL | 090912-001 | Jul 27, 2011 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for acarbose
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | PRECOSE | acarbose | TABLET;ORAL | 020482-004 | May 29, 1997 | ⤷ Sign Up | ⤷ Sign Up |
| Bayer Hlthcare | PRECOSE | acarbose | TABLET;ORAL | 020482-002 | Sep 6, 1995 | ⤷ Sign Up | ⤷ Sign Up |
| Bayer Hlthcare | PRECOSE | acarbose | TABLET;ORAL | 020482-001 | Sep 6, 1995 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
